glp 1 gastric emptying GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Anti-obesity drugs for the gastroenterologist

Drugs such as semaglutide may be useful for mental health conditions associated with diabetes, authors say

lactis B420, an exclusive strain clinically studied for women over 50 and during menopause

Timeline varies significantly based on dosing schedule, baseline metabolic factors, adherence, and individual genetic predispositions in GLP-1 signaling pathways

Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as breakthrough drugsin 2023 and their popularity has soared since. More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/20261, while around2.5 million people each monthaccessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of []

Risk of bias was assessed using an adapted Quality Assessment Tool for In Vitro Studies (QUIN) tool

Combined SGLT2 inhibitor and GLP-1 receptor agonist therapy could provide additional cardiovascular and renal benefits for adults with type 2 diabetes, according to data from a meta-analysis published in The Lancet Diabetes &amp